Clinical outcomes of coronavirus disease 2019 (COVID‐19) in cancer patients with prior exposure to immune checkpoint inhibitors

Detalles Bibliográficos
Autores principales: Wu, Qiuji, Chu, Qian, Zhang, Hongyan, Yang, Bin, He, Xudong, Zhong, Yahua, Yuan, Xianglin, Chua, Melvin L.K., Xie, Conghua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405291/
https://www.ncbi.nlm.nih.gov/pubmed/32666636
http://dx.doi.org/10.1002/cac2.12077

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7405291/
https://www.ncbi.nlm.nih.gov/pubmed/32666636
http://dx.doi.org/10.1002/cac2.12077

Ejemplares similares